BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$151M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$126M |
| 3 |
Alibaba
BABA
|
+$92.6M |
| 4 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$71M |
| 5 |
Lam Research
LRCX
|
+$54.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$1.15B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Apple
AAPL
|
+$837M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$723M |
| 5 |
Microsoft
MSFT
|
+$603M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.13% |
| 2 | Financials | 5.89% |
| 3 | Healthcare | 5.09% |
| 4 | Consumer Discretionary | 5% |
| 5 | Communication Services | 3.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
AZZ Inc
AZZ
$4.55B
| $64.6K | ﹤0.01% |
1,600
+76
| +5% | +$3.44K |
|
|
PTLA
2502
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $64.5K | ﹤0.01% |
3,304
-1,719
| -34% | -$35.4K |
|
2503
Valvoline
VVV
$4.36B
| $64.4K | ﹤0.01% |
3,329
-16,547
| -83% | -$331K |
|
2504
Enviri
NVRI
$579M
| $64.4K | ﹤0.01% |
3,242
-1,428
| -31% | -$35.4K |
|
2505
Nu Skin
NUS
$234M
| $64.3K | ﹤0.01% |
1,049
-70,362
| -99% | -$4.75M |
|
2506
Veeco
VECO
$3.2B
| $64.2K | ﹤0.01% |
8,668
-3,751
| -30% | -$32.1K |
|
2507
PUT
Bath & Body Works
BBWI
$3.91B
| $64.2K | ﹤0.01% |
31
-424
| -93% | -$10.7K |
|
2508
First Interstate BancSystem
FIBK
$3.73B
| $63.8K | ﹤0.01% |
1,746
-316
| -15% | -$13.1K |
|
2509
Acco Brands
ACCO
$401M
| $63.6K | ﹤0.01% |
9,374
-3,906
| -29% | -$33.4K |
|
|
NUVA
2510
DELISTED
NuVasive, Inc.
NUVA
| $63.2K | ﹤0.01% |
1,275
-5,021
| -80% | -$302K |
|
2511
Helix Energy Solutions
HLX
$1.54B
| $63.1K | ﹤0.01% |
11,669
+3,444
| +42% | +$28.1K |
|
2512
CALL
State Street
STT
$52.7B
| $63.1K | ﹤0.01% |
10
| – | – |
|
2513
Columbia Banking Systems
COLB
$9.25B
| $62.8K | ﹤0.01% |
1,731
-2,468
| -59% | -$92.4K |
|
2514
Cable One
CABO
$196M
| $62.3K | ﹤0.01% |
76
-400
| -84% | -$346K |
|
2515
National Presto Industries
NPK
$1B
| $62.2K | ﹤0.01% |
532
+248
| +87% | +$31.1K |
|
|
MCRN
2516
DELISTED
Milacron Holdings Corp.
MCRN
| $61.9K | ﹤0.01% |
5,209
+1,115
| +27% | +$16.8K |
|
2517
Kirby Corp
KEX
$7.32B
| $61.9K | ﹤0.01% |
919
-2,933
| -76% | -$217K |
|
|
WW
2518
DELISTED
WW International
WW
| $61.9K | ﹤0.01% |
1,605
-2,492
| -61% | -$137K |
|
2519
Albany International
AIN
$1.84B
| $61.7K | ﹤0.01% |
988
-685
| -41% | -$47.8K |
|
|
MFGP
2520
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
| $61.6K | ﹤0.01% |
2,960
-11
| -0.4% | -$236 |
|
|
NTRI
2521
DELISTED
NutriSystem, Inc.
NTRI
| $61.6K | ﹤0.01% |
1,403
-15,334
| -92% | -$579K |
|
2522
CVB Financial
CVBF
$4.09B
| $61.4K | ﹤0.01% |
3,037
-18,944
| -86% | -$411K |
|
2523
E.W. Scripps
SSP
$320M
| $61.1K | ﹤0.01% |
3,885
+948
| +32% | +$15.8K |
|
2524
Omnicell
OMCL
$1.7B
| $61.1K | ﹤0.01% |
997
-1,096
| -52% | -$74.2K |
|
|
STL
2525
DELISTED
Sterling Bancorp
STL
| $60.9K | ﹤0.01% |
3,689
-47,529
| -93% | -$885K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2018 Portfolio in Review
As of Q4 2018, BNP Paribas Financial Markets held 4,572 positions worth $42.3B, down 38% from $67.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BNP Paribas Financial Markets withdrew a net $18.9B in Q4 2018, closing 248 positions and reducing 2,296 holdings. Its most notable exit was Aetna Inc, an estimated $141M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.1% of assets, down from 9.7% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in HUTCHMED worth $8.84M.
- BNP Paribas Financial Markets's largest Q4 2018 buy was HUTCHMED: 382,749 shares worth $8.84M.
- BNP Paribas Financial Markets added most to Celgene Corp in Q4 2018, an estimated $151M increase.
- BNP Paribas Financial Markets's biggest Q4 2018 reduction was Alphabet (Google) Class C, cutting an estimated $1.15B.
- BNP Paribas Financial Markets fully exited Aetna Inc in Q4 2018, selling an estimated $141M.
- BNP Paribas Financial Markets's ten largest holdings make up 19% of its $42.3B portfolio in Q4 2018.
- BNP Paribas Financial Markets opened 126 new positions and closed 248 in Q4 2018.
- BNP Paribas Financial Markets's portfolio value fell 38% quarter-over-quarter to $42.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2018, filed 12 Feb 2019.